OptimizeRx Corp (OPRX)
7.75
+0.22
(+2.92%)
USD |
NASDAQ |
Sep 27, 16:00
7.74
-0.01
(-0.13%)
Pre-Market: 20:00
OptimizeRx Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2019 | 2.282M |
| September 30, 2019 | 1.668M |
| June 30, 2019 | 0.7485M |
| March 31, 2019 | 0.6459M |
| December 31, 2018 | 0.7163M |
| September 30, 2018 | 0.8364M |
| June 30, 2018 | 0.825M |
| March 31, 2018 | 0.7939M |
| December 31, 2017 | 0.7431M |
| September 30, 2017 | 0.5411M |
| June 30, 2017 | 0.5351M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.5196M |
| December 31, 2016 | 0.3984M |
| September 30, 2016 | 0.6024M |
| June 30, 2016 | 0.5809M |
| March 31, 2016 | 0.5646M |
| December 31, 2015 | 0.5404M |
| September 30, 2015 | 0.2459M |
| June 30, 2015 | 0.2283M |
| March 31, 2015 | 0.2078M |
| December 31, 2014 | 0.1896M |
| September 30, 2014 | 0.0062M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.668M
Minimum
Sep 2019
2.282M
Maximum
Dec 2019
1.975M
Average
1.975M
Median